Download PDFPDF

6ER-024 Comparison of reductions in monthly migraine days between new small molecule cgrp receptor antagonists (gepants) and monoclonal antibodies targeting cgrp/cgrp receptor
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address